Brazilian approval of Sputnik V vaccine delayed by missing data

BRASILIA — Brazil’s health regulator is seeking further data on Russia’s Sputnik V coronavirus vaccine before considering its approval for emergency use.

Documents supporting drugmaker Uniao Quimica’s application for emergency use of the vaccine have been returned to the company because they did not meet its minimum criteria, the watchdog said on Saturday.

In a statement on the Health Ministry’s website, regulator Anvisa said the request failed to provide adequate assurances on Phase III clinical trials and issues related to the manufacture of the vaccine.

Uniao Quimica is seeking approval for the use of 10 million doses of Sputnik V in Brazil in the first quarter of this year.

Russia’s RDIF sovereign wealth fund, which is promoting Sputnik globally, on Sunday said that Anvisa had requested additional information that would be provided shortly.

Its statement said that such requests from regulators were standard procedure and do not mean the registration bid has been rejected. It also said that legislation going through the Brazilian Senate, if approved, would allow use of vaccines approved by other countries.

Moscow has approved Sputnik for Russian domestic use, though clinical trials there have not yet been completed.

Football news:

Pioli about Milan: We are proud that we have a young team, but we need stability
Laporta became president of Barcelona again. Under him, the club took 6 trophies in 2009
Mourinho on 4-1 with Palace: Good week. At half-time, he said he was happy to concede a goal, the players thought I was crazy
Liverpool dropped to 8th place in the Premier League, on lost points - 9th
Xavi won the 6th trophy in his coaching career. His Al-Sadd became the champion of Qatar
Laporta is ahead of Font and Freixa according to the results of the poll of those who voted in the election of the president of Barca
Solskjaer won all 3 matches with Manchester United in the away match against Man City. This is a club record